Rege Nephro

About:

Rege Nephro is a biotech company that specializes in R&D, production, and marketing of renal disease therapeutics.

Website: https://www.regenephro.co.jp

Top Investors: Global Brain Corporation, SMBC Venture Capital, Mitsubishi UFJ Capital, Asahi Kasei, Kyoto University Innovation Capital

Description:

Rege Nephro is a biotech company specializing in R&D, production, and marketing of renal disease therapeutics. It utilizes induced pluripotent stem cell (iPSC)-based technology from the Center for iPS Cell Research and Application (CiRA), Kyoto University. It is developing therapeutics and cell therapy for kidney, liver, and pancreas diseases.